We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Amgen to Pay $71 Million Over Aranesp, Enbrel False Claims
Amgen to Pay $71 Million Over Aranesp, Enbrel False Claims
Amgen agreed Tuesday to pay $71 million to 48 states and the District of Columbia to resolve allegations it promoted biologics Aranesp and Enbrel based on misleading claims.